A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
Condition: Infections, BacterialInterventions: Drug: GSK1322322; Drug: EE/NE; Drug: GSK1322322 Placebo; Drug: EE/NE PlaceboSponsor: GlaxoSmithKlineWithdrawn - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials